Production

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

One of the leading manufacturers in pharmaceuticals. interme -diates fine chemicals company is establishing a modem R&D center,API and formulations manufacturing at TTC Navi Mumbai looking for cGMP.USFDA accreditation & looking for professionals with relevant

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base. Having four multi product facilities in operation and two research centers, SMS has truly graduated into big league with more than 1000 employees working for it.

We, Gufic Lifesciences Private Limited is coming with manufacturing facilities of PIC's, MHRA, USFDA requirement for formulation of Lyophilization injectables at Navsari (Gujarat) for which we are looking for competent candidates.

In view of existing operational requirement and future expansions, it is proposed to recruit quality educational freshers from different locations across India, as a part of this we have planned Walk-in Interviews at HETERO(Corporate), Sanathnagar on 25th Nov, 2016 and the details are as follows: Requirement Details:

Post : Junior Officer/ Junior Research Associate/chemist - Formulations

Unimed Technologies Limited  the manufacturer of small volume parenteral products, injoctabios, inhalation & liposome products and long acting depot preparation. A trusted name in the field, the company has a strong presence in national as well as International markets Among others, rt counts Australia. China. Russia. Sri Lanka. Myanmar. Belarus and Philippines as koy markets for exports. Unimed's manufactunng plant has been approved by global regulatory authorities such as the US FDA (USA), ANVISA (Brazil). PPB (Kenya). TFDA (Tanzania), MOH (Kazakhstan) and FDA (Philippines) To keep pace with our growth plans, we require for our Formulation (Parenterals) manufacturing plant at Baska. near Baroda. Gujarat.

Lini Infotech is driven by strong leadership with a long term focus which strives towards excellence by envisioning the future. As an organization, We are proud to share that many of our clients have chosen to partner us for long time. This speaks volumes about the type of long-term relationships we cultivate with our clients whom we cherish deeply We provide maximum business value while fulfilling your business imperatives by employing the right people, processes and technology. After all, our clients are the best judges of what we do and how we do it

Post : Bsc/Msc Freshers

Caplin Point Laboratories Ltd generate over US$50 million in revenue annually with a healthy bottom line. We have recently been selected by Forbes Asia magazine as one of the Top 200 best performing companies in Asia, for the second time in a row. Caplin is the only Pharma company in India to be selected in both 2014 and 2015. We have been manufacturing, exporting and distributing our products to Latin America and Africa for the last 16 years and we're already in the Top 5 exporters from India to Latin America over the last few years. We are currently holding over 2000 product licenses in these regions with another 490 in the pipeline. Our latest Injectable facility in Gummidipoondi, built with a budget of HOcr has been funded entirely from internal accruals. The injectable factory has been approved by European Union and Brazil, with US FDA inspection likely to take place by 2016 last quarter.